Recent studies have shown that NFIB promotes proliferation and reduces apoptosis of CRC cells4, triple-negative breast cancer cells5, bladder cancer cells6 and laryngeal squamous cell carcinoma cells7. The gene discussed is NFIB; the disease is colorectal carcinoma.